Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes
出版年份 2021 全文链接
标题
Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes
作者
关键词
-
出版物
Cardiovascular Diabetology
Volume 20, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-02-14
DOI
10.1186/s12933-021-01235-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)
- (2020) Ayako Fuchigami et al. Cardiovascular Diabetology
- Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a randomized controlled trial
- (2020) Hassan B. Awal et al. Cardiovascular Diabetology
- Using adult stem cells to monitor endothelial dysfunction in diabetes mellitus
- (2020) Rohit Jain et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review
- (2019) Venkatesan Thiruvenkatarajan et al. BRITISH JOURNAL OF ANAESTHESIA
- Acute canagliflozin treatment protects against in vivo myocardial ischemia–reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxation
- (2019) Alex Ali Sayour et al. Journal of Translational Medicine
- Endothelial Dysfunction: Is There a Hyperglycemia-Induced Imbalance of NOX and NOS?
- (2019) Cesar A. Meza et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial
- (2018) Fiona J. Dore et al. Cardiovascular Diabetology
- Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function: Data from the CANVAS Program
- (2018) Brendon L. Neuen et al. CIRCULATION
- Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)
- (2018) Karin Rådholm et al. CIRCULATION
- Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non-SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real-world meta-analysis of 4 observational databases (OBSER
- (2018) Patrick B. Ryan et al. DIABETES OBESITY & METABOLISM
- Shear stress: An essential driver of endothelial progenitor cells
- (2018) Anton G. Kutikhin et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study
- (2018) Elisabetta Patorno et al. BMJ-British Medical Journal
- Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study
- (2018) Elisabetta Patorno et al. BMJ-British Medical Journal
- Effects of SGLT-2 inhibitors on circulating stem and progenitor cells in patients with type 2 diabetes
- (2018) Benedetta Maria Bonora et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus
- (2018) Raimunda S. S. Azevedo et al. Scientific Reports
- Circulating Stem/Progenitor Cells as Prognostic Biomarkers in Macro- and Microvascular Disease: A Narrative Review of Prospective Observational Studies
- (2018) Mauro Rigato et al. CURRENT MEDICINAL CHEMISTRY
- Canagliflozin, a sodium glucose cotransporter 2 inhibitor, attenuates obesity-induced inflammation in the nodose ganglion, hypothalamus, and skeletal muscle of mice
- (2017) Farhana Naznin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Correlation of Arterial Stiffness with Biophysical Parameters and Blood Biochemistry
- (2017) Anamil M. Khiyami et al. Metabolic Syndrome and Related Disorders
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crosstalk between Stem and Progenitor Cellular Mediators with Special Emphasis on Vasculogenesis
- (2017) Rokhsareh Rohban et al. TRANSFUSION MEDICINE AND HEMOTHERAPY
- Endothelial Progenitors: A Consensus Statement on Nomenclature
- (2017) Reinhold J. Medina et al. Stem Cells Translational Medicine
- SGLT2 inhibitors and amputations in the US FDA Adverse Event Reporting System
- (2017) Gian Paolo Fadini et al. Lancet Diabetes & Endocrinology
- The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
- (2017) Sebastian Steven et al. Redox Biology
- Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events
- (2017) Kenneth W. Mahaffey et al. CIRCULATION
- Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study? A Unifying Hypothesis
- (2016) Sunder Mudaliar et al. DIABETES CARE
- Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus
- (2015) Norm Rosenthal et al. Annals of the New York Academy of Sciences
- Renal effects of canagliflozin in type 2 diabetes mellitus
- (2015) Vlado Perkovic et al. CURRENT MEDICAL RESEARCH AND OPINION
- Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications
- (2015) Hasniza Zaman Huri et al. Drug Design Development and Therapy
- Inhibition of Renal Glucose Reabsorption: A Novel Strategy for Achieving Glucose Control in Type 2 Diabetes Mellitus
- (2013) Muhammad Abdul-Ghani et al. Endocrine Practice
- Sustained delivery of SDF-1α from heparin-based hydrogels to attract circulating pro-angiogenic cells
- (2012) Silvana Prokoph et al. BIOMATERIALS
- Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine
- (2011) G. P. Fadini et al. DIABETES OBESITY & METABOLISM
- Need for better diabetes treatment for improved renal outcome
- (2011) Peter Rossing et al. KIDNEY INTERNATIONAL
- Recent and Emerging Therapeutic Medications in Type 2 Diabetes Mellitus
- (2010) Margaret C. Lo et al. AMERICAN JOURNAL OF THERAPEUTICS
- Oxidative Stress and Diabetic Complications
- (2010) Ferdinando Giacco et al. CIRCULATION RESEARCH
- Sodium–glucose transport: role in diabetes mellitus and potential clinical implications
- (2010) Volker Vallon et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started